About
Envisioned by a group sharing passions for both animals and science, SentrX from the beginning has been devoted to revolutionary veterinary care. With wound treatment products developed specifically for horses and small animals, SentrX transforms complex biotechnologies into easy-to-use care solutions that promote the long-term wellbeing of animals.
Background
SentrX Animal Care was founded on technology from the University of Utah and collaborates with a variety of veterinary academic institutions, practicing veterinarians, and is led by a board of distinguished industry leaders. The company's unique mix of medicinal chemistry, bioengineering, and product manufacturing capabilities allows it to deliver truly cutting-edge animal care solutions.
Fast Facts
SentrX wound care treatment products have been tested and have shown success in 7 animal species, including horses and dogs.
More than 30 studies have appeared in peer-reviewed scientific literature showing the use of SentrX products to promote superior healing of tissues.
Use of SentrX products reduces time of treatment by 50% in several different applications.
In 8-week studies of several animal models, wounds treated with SentrX showed the same level of healing at Week 4 as non-SentrX treated wounds showed at Week 8.
SentrX products are currently involved in animal studies at Cornell University and the University of Pennsylvania.
The biotechnologies developed by SentrX have proven so innovative, they have been incorporated into two additional companies for use in human therapeutics and drug evaluation.
SentrX Leadership
Richard K. Koehn, Ph.D.
Co-founder, President and CEO
A consultant to the venture capital business for over 12 year, he was Entrepeneur of the Year in 1991. As CEO of Salus Therapeutics, he negotiated it's acquisition by Genta, Inc. In 2005, he negotiated a $7.5M investment in Sentrx Surgical leading to the creation of Carbylan BioSurgery and Sentrx Animal Care. Founding Director of the Center for Advanced Biomedical Technology in NY, VP for Research at the University of Utah (1992-2000), in 2005, Koehn was awarded the Governor's Medal in Science and Technology.
Brenda K. Mann, Ph.D.
Co-founder and COO
B.S. (1991), Chemical Engineering, Iowa State University; Ph.D. (1997), Chemical Engineering, Rice University. Dr. Mann has extensive experience in the development of hydrogels for tissue engineering and wound healing applications. She received the Rice University Outstanding Woman Award in 1996, and the Young Investigator Award from the International Society for Applied Cardiovascular Biology in 2000. Dr. Mann was a founding faculty member of the Keck Graduate Institute of Applied Life Sciences, and now serves on it's Advisory Council. She is a Research Assistant Professor in the Department of Bioengineering at the University of Utah and holds an adjunct faculty position at the University of texas at El Paso. Dr. Mann is also a registered patent agent.
Glenn D. Prestwich, Ph.D.
Co-founder and Senior Scientific Advisor
Presidential Professor of Medicinal Chemistry, The University of Utah (1996-present); B.Sc. (1970), Chemistry, California Institute of Technology; Ph.D. (1974), Chemistry, Stanford University; Alfred P. Sloan Research and Dreyfus Teacher-Scholar Awards; 1998 Paul Dawson Biotechnology Award (AACP); Fellow of American Institute for Medical and Biological Engineering Professor of Chemistry, Stony Brook University (1977-1996); Director, Center for Biotechnology (Stony Brook, 1992-1996); Director, Center for Cell Signaling (2002-2007); Director, Center for Therapeutic Biomaterials (2004-present). Co-founder and former CSO of Eschelon Biosciences, Inc.; co-founder and former CSO, Sentrx Surgical, Inc.; Senior Scientific Advisor, Carbylan BioSurgery, Inc. (Palo Alto, CA); Co-founfer and CSO Glycosan Biosystems, Inc. Dr. Prestwich has published over 556 papers, patents, book chapters; he trained over 69 graduate students and 53 postdocs in 30 years.
Board of Directors
Richard K. Koehn, Ph.D.
Chairman, President and CEO
A consultant to the venture capital business for over 12 year, he was Entrepeneur of the Year in 1991. As CEO of Salus Therapeutics, he negotiated it's acquisition by Genta, Inc. In 2005, he negotiated a $7.5M investment in Sentrx Surgical leading to the creation of Carbylan BioSurgery and Sentrx Animal Care. Founding Director of the Center for Advanced Biomedical Technology in NY, VP for Research at the University of Utah (1992-2000), in 2005, Koehn was awarded the Governor's Medal in Science and Technology.
Stephen H. Blose, Ph.D., V.M.D.
Director
Steve is the CEO of the Mill Valley Summit Group, LLC. advising start-up companies, and venture capital firms on investments/acquisitions in life sciences. MVSG has raised more than $35M of venture financing. Steve was the Division General Manager, Imaging Products Division, at Bio-Rad Laboratories Inc. He was president and CEO of Protein Databases, Inc. (PDI), a global proteomic products company. Steve was one pf the founders of the proteomics industry while at the Cold Springs Harbor Laboratory working with Dr. James D. Watson. Steve held joint academic appointments at the Schools of Medicine and Veterinary Medicine, University of Pennsylvania.
Bill Mott
Director
Bill was the 1995 Trainer of the Year when his star horse, Cigar, won 10 of 10 races earning over $4.5M and continuing his winning streak. Besides Cigar, in 1995, he won 35 stakes races with 22 different horses, and he ranked 2nd in earnings with $11.7M. Mott has also won nine training titles at the historic Churchhill Downs. Besides Cigar, he has trained two other eclipse award winning horses, including Theatrical in 1987 and Arlington million winner Paradise Creek in 1984.
Nathaniel A. White, II, D.V.M., M.S., Diplomate ACVS
Director
Dr. White is the Jean Ellen Shehan Professor and Director of the Marion duPont Scott Equine Medical Center at the Virginia-Maryland Regional College of Veterinary Medicine and an Adjunct Professor at the University of Maryland. His education encompassed Cornell (DVM '71), Internshipo and Residency in Surgery at UC Davis ('71-'73) and MS in pathology at Kansas State University ('76). Dr. White served as president of the American College of Veterinary Surgeons and the ACVS Research and Education Foundation. He is past Director at Large and currently Chair of the AAEP Foundation Advisory Committee as well as Director of the ACVS Veterinary Symposium. Dr. White has authored or co-authored 147 journal articles and 35 book chapters and is the editor and author of The Equine Acute Abdomen, Current Techniques in Equine Surgery and Lameness and Handbook of Equine Colic.
Hugh B. Lewis, BVMS, MRCVS, Dipl., ACVP
Director
Dr. Lewis is a Senior Vice President of Practice Development and President of DataSavant, LLC., at Banfield, The Pet Hospital. Banfield is one of the largest small animal HMOs in the US with more than 620 small animal clinics nation-wide and additional clinics in the UK and Mexico. Dr. Lewis has been a member of the faculty in the School of Veterinary MEdicine at the University of Pennsylvania and is former Dean of Veterinary Medicine at Purdue University.
